Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pertussis: Biology, epidemiology and prevention.

Identifieur interne : 003D70 ( Ncbi/Curation ); précédent : 003D69; suivant : 003D71

Pertussis: Biology, epidemiology and prevention.

Auteurs : Mitra Saadatian-Elahi [France] ; Stanley Plotkin [États-Unis] ; Kingston H G. Mills [Irlande (pays)] ; Scott A. Halperin [Canada] ; Peter B. Mcintyre [Australie] ; Valentina Picot [France] ; Jacques Louis [France] ; David R. Johnson [États-Unis]

Source :

RBID : pubmed:27780629

Abstract

Despite long-standing vaccination programs, substantial increases in reported cases of pertussis have been described in several countries during the last 5years. Cases among very young infants who are at greatest risk of pertussis-related hospitalizations and mortality are the most alarming. Multiple hypotheses including but not limited to the availability of more sensitive diagnostic tests, greater awareness, and waning vaccine-induced immunity over time have been posited for the current challenges with pertussis. The conference "Pertussis: biology, epidemiology and prevention" held in Annecy-France (November 11-13, 2015) brought together experts and interested individuals to examine these issues and to formulate recommendations for optimal use of current vaccines, with a particular focus on strategies to minimize severe morbidity and mortality among infants during the first months of life. The expert panel concluded that improving vaccination strategies with current vaccines and development of new highly immunogenic and efficacious pertussis vaccines that have acceptable adverse event profiles are currently the two main areas of investigation for the control of pertussis. Some possible pathways forward to address these main challenges are discussed in this report.

DOI: 10.1016/j.vaccine.2016.10.029
PubMed: 27780629

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:27780629

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pertussis: Biology, epidemiology and prevention.</title>
<author>
<name sortKey="Saadatian Elahi, Mitra" sort="Saadatian Elahi, Mitra" uniqKey="Saadatian Elahi M" first="Mitra" last="Saadatian-Elahi">Mitra Saadatian-Elahi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Pôle Santé, Recherche, Risques et Vigilances Groupement Hospitalier Edouard Herriot, Unité d'Hygiène, Epidémiologie et Prévention, 5 Place d'Arsonval, 69437 Lyon cedex 03, France. Electronic address: mitra.elahi@chu-lyon.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pôle Santé, Recherche, Risques et Vigilances Groupement Hospitalier Edouard Herriot, Unité d'Hygiène, Epidémiologie et Prévention, 5 Place d'Arsonval, 69437 Lyon cedex 03</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Plotkin, Stanley" sort="Plotkin, Stanley" uniqKey="Plotkin S" first="Stanley" last="Plotkin">Stanley Plotkin</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Pennsylvania and Vaxconsult, LLC, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Pennsylvania and Vaxconsult, LLC</wicri:regionArea>
<wicri:noRegion>LLC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mills, Kingston H G" sort="Mills, Kingston H G" uniqKey="Mills K" first="Kingston H G" last="Mills">Kingston H G. Mills</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Halperin, Scott A" sort="Halperin, Scott A" uniqKey="Halperin S" first="Scott A" last="Halperin">Scott A. Halperin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Canadian Centre for Vaccinology, Dalhousie University, The IWK Health Centre and Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Centre for Vaccinology, Dalhousie University, The IWK Health Centre and Nova Scotia Health Authority, Halifax, Nova Scotia</wicri:regionArea>
<wicri:noRegion>Nova Scotia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mcintyre, Peter B" sort="Mcintyre, Peter B" uniqKey="Mcintyre P" first="Peter B" last="Mcintyre">Peter B. Mcintyre</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Picot, Valentina" sort="Picot, Valentina" uniqKey="Picot V" first="Valentina" last="Picot">Valentina Picot</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon</wicri:regionArea>
<wicri:noRegion>69002 Lyon</wicri:noRegion>
<placeName>
<settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Louis, Jacques" sort="Louis, Jacques" uniqKey="Louis J" first="Jacques" last="Louis">Jacques Louis</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon</wicri:regionArea>
<wicri:noRegion>69002 Lyon</wicri:noRegion>
<placeName>
<settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Johnson, David R" sort="Johnson, David R" uniqKey="Johnson D" first="David R" last="Johnson">David R. Johnson</name>
<affiliation wicri:level="2">
<nlm:affiliation>Global Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Global Medical Affairs, Sanofi Pasteur, Swiftwater, PA</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27780629</idno>
<idno type="pmid">27780629</idno>
<idno type="doi">10.1016/j.vaccine.2016.10.029</idno>
<idno type="wicri:Area/PubMed/Corpus">001671</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001671</idno>
<idno type="wicri:Area/PubMed/Curation">001649</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001649</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001649</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001649</idno>
<idno type="wicri:Area/Ncbi/Merge">003D70</idno>
<idno type="wicri:Area/Ncbi/Curation">003D70</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pertussis: Biology, epidemiology and prevention.</title>
<author>
<name sortKey="Saadatian Elahi, Mitra" sort="Saadatian Elahi, Mitra" uniqKey="Saadatian Elahi M" first="Mitra" last="Saadatian-Elahi">Mitra Saadatian-Elahi</name>
<affiliation wicri:level="3">
<nlm:affiliation>Pôle Santé, Recherche, Risques et Vigilances Groupement Hospitalier Edouard Herriot, Unité d'Hygiène, Epidémiologie et Prévention, 5 Place d'Arsonval, 69437 Lyon cedex 03, France. Electronic address: mitra.elahi@chu-lyon.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Pôle Santé, Recherche, Risques et Vigilances Groupement Hospitalier Edouard Herriot, Unité d'Hygiène, Epidémiologie et Prévention, 5 Place d'Arsonval, 69437 Lyon cedex 03</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Plotkin, Stanley" sort="Plotkin, Stanley" uniqKey="Plotkin S" first="Stanley" last="Plotkin">Stanley Plotkin</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Pennsylvania and Vaxconsult, LLC, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Pennsylvania and Vaxconsult, LLC</wicri:regionArea>
<wicri:noRegion>LLC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mills, Kingston H G" sort="Mills, Kingston H G" uniqKey="Mills K" first="Kingston H G" last="Mills">Kingston H G. Mills</name>
<affiliation wicri:level="1">
<nlm:affiliation>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.</nlm:affiliation>
<country xml:lang="fr">Irlande (pays)</country>
<wicri:regionArea>School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2</wicri:regionArea>
<wicri:noRegion>Dublin 2</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Halperin, Scott A" sort="Halperin, Scott A" uniqKey="Halperin S" first="Scott A" last="Halperin">Scott A. Halperin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Canadian Centre for Vaccinology, Dalhousie University, The IWK Health Centre and Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Canadian Centre for Vaccinology, Dalhousie University, The IWK Health Centre and Nova Scotia Health Authority, Halifax, Nova Scotia</wicri:regionArea>
<wicri:noRegion>Nova Scotia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mcintyre, Peter B" sort="Mcintyre, Peter B" uniqKey="Mcintyre P" first="Peter B" last="Mcintyre">Peter B. Mcintyre</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Picot, Valentina" sort="Picot, Valentina" uniqKey="Picot V" first="Valentina" last="Picot">Valentina Picot</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon</wicri:regionArea>
<wicri:noRegion>69002 Lyon</wicri:noRegion>
<placeName>
<settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Louis, Jacques" sort="Louis, Jacques" uniqKey="Louis J" first="Jacques" last="Louis">Jacques Louis</name>
<affiliation wicri:level="1">
<nlm:affiliation>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Fondation Mérieux, 17 rue Bourgelat, 69002 Lyon</wicri:regionArea>
<wicri:noRegion>69002 Lyon</wicri:noRegion>
<placeName>
<settlement type="city">Lyon</settlement>
<region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Johnson, David R" sort="Johnson, David R" uniqKey="Johnson D" first="David R" last="Johnson">David R. Johnson</name>
<affiliation wicri:level="2">
<nlm:affiliation>Global Medical Affairs, Sanofi Pasteur, Swiftwater, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Global Medical Affairs, Sanofi Pasteur, Swiftwater, PA</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Vaccine</title>
<idno type="eISSN">1873-2518</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Despite long-standing vaccination programs, substantial increases in reported cases of pertussis have been described in several countries during the last 5years. Cases among very young infants who are at greatest risk of pertussis-related hospitalizations and mortality are the most alarming. Multiple hypotheses including but not limited to the availability of more sensitive diagnostic tests, greater awareness, and waning vaccine-induced immunity over time have been posited for the current challenges with pertussis. The conference "Pertussis: biology, epidemiology and prevention" held in Annecy-France (November 11-13, 2015) brought together experts and interested individuals to examine these issues and to formulate recommendations for optimal use of current vaccines, with a particular focus on strategies to minimize severe morbidity and mortality among infants during the first months of life. The expert panel concluded that improving vaccination strategies with current vaccines and development of new highly immunogenic and efficacious pertussis vaccines that have acceptable adverse event profiles are currently the two main areas of investigation for the control of pertussis. Some possible pathways forward to address these main challenges are discussed in this report.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D70 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003D70 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:27780629
   |texte=   Pertussis: Biology, epidemiology and prevention.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:27780629" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024